Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) and Sanofi SA (NASDAQ:SNY) presented new, detailed results from the RELIEVE ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...
Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...
Bank Leumi (TASE: LUMI) led the market today, falling 1.02% on the day's biggest trading turnover. Bank Hapoalim (TASE: POLI) fell 1.37%, Mizrahi Tefahot Bank fell 0.53% and Israel Discount Bank (TASE ...
Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen ...
Alibaba's Q3/25 results were strong, with significant revenue and EPS growth. Click here to read why BABA stock remains a ...
What has been 52-week high of Kiri Industries Ltd stocks? The highest price of Kiri Industries Ltd stock is ₹699.90 in the last 52-week. What is the share price of Kiri Industries Ltd (KIRIINDUS ...
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...
Bloomberg's Caroline Hyde and Jackie Davalos break down Apple's $500 billion investment in the US and the company's plans to boost hiring as it seeks relief from President Trump's tariffs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results